ATE127691T1 - Verwendung von vitamin-d-analoga zur behandlung von akne. - Google Patents

Verwendung von vitamin-d-analoga zur behandlung von akne.

Info

Publication number
ATE127691T1
ATE127691T1 AT91905594T AT91905594T ATE127691T1 AT E127691 T1 ATE127691 T1 AT E127691T1 AT 91905594 T AT91905594 T AT 91905594T AT 91905594 T AT91905594 T AT 91905594T AT E127691 T1 ATE127691 T1 AT E127691T1
Authority
AT
Austria
Prior art keywords
pct
vitamin
analogue
preparation
sec
Prior art date
Application number
AT91905594T
Other languages
English (en)
Inventor
Wagn Ole Godtfredsen
Original Assignee
Leo Pharm Prod Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Leo Pharm Prod Ltd filed Critical Leo Pharm Prod Ltd
Application granted granted Critical
Publication of ATE127691T1 publication Critical patent/ATE127691T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K8/00—Cosmetics or similar toiletry preparations
    • A61K8/18—Cosmetics or similar toiletry preparations characterised by the composition
    • A61K8/30—Cosmetics or similar toiletry preparations characterised by the composition containing organic compounds
    • A61K8/67—Vitamins
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61Q—SPECIFIC USE OF COSMETICS OR SIMILAR TOILETRY PREPARATIONS
    • A61Q19/00—Preparations for care of the skin

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Medicinal Chemistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Dermatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Birds (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Cosmetics (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
AT91905594T 1990-03-01 1991-02-25 Verwendung von vitamin-d-analoga zur behandlung von akne. ATE127691T1 (de)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB909004544A GB9004544D0 (en) 1990-03-01 1990-03-01 Novel treatment ii

Publications (1)

Publication Number Publication Date
ATE127691T1 true ATE127691T1 (de) 1995-09-15

Family

ID=10671792

Family Applications (1)

Application Number Title Priority Date Filing Date
AT91905594T ATE127691T1 (de) 1990-03-01 1991-02-25 Verwendung von vitamin-d-analoga zur behandlung von akne.

Country Status (11)

Country Link
US (1) US5292727A (de)
EP (1) EP0517797B1 (de)
JP (1) JPH05504959A (de)
AT (1) ATE127691T1 (de)
AU (1) AU7458891A (de)
DE (1) DE69113029T2 (de)
DK (1) DK0517797T3 (de)
ES (1) ES2079063T3 (de)
GB (1) GB9004544D0 (de)
GR (1) GR3017413T3 (de)
WO (1) WO1991012807A1 (de)

Families Citing this family (37)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5362719A (en) * 1990-03-01 1994-11-08 Leo Pharmaceutical Products, Ltd. A/S Lovens Kemiske Fabrik Produktionsaktieselskab) Use of vitamin-D analogues in the treatment of acne
GB9300763D0 (en) * 1993-01-15 1993-03-03 Leo Pharm Prod Ltd Chemical compound
US5384314B1 (en) * 1994-03-11 1997-08-05 Hoffmann La Roche 1alpha-fluoro-25-hydroxy-16-ene-23-yne-cholecalciferol
PE28297A1 (es) * 1995-01-26 1997-08-20 Hoffmann La Roche Empleo dermatologico de derivados de vitamina d
EP0835853A1 (de) * 1996-10-14 1998-04-15 Societe Europeenne De Propulsion Reibelement aus Kohlenstoff/Kohlenstoff-Siliciumcarbidverbundwerkstoff und Verfahren zu seiner Herstellung
EP1040832A4 (de) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Vitamin d3 enthaltende cremen
EP1051974A4 (de) * 1997-12-09 2001-09-12 Chugai Pharmaceutical Co Ltd Vitamin-d3-derivate enthaltende lotionen
US6491936B1 (en) 1997-12-09 2002-12-10 Chugai Seiyaku Kabushiki Kaisha Creams containing vitamin D3 derivatives
US8263580B2 (en) * 1998-09-11 2012-09-11 Stiefel Research Australia Pty Ltd Vitamin formulation
PT3146969T (pt) * 1999-04-23 2018-10-18 Leo Pharma As Composição farmacêutica para aplicação dérmica para uso no tratamento da psoríase compreendendo vitamina d e um corticosteroide
CN1179725C (zh) 1999-08-31 2004-12-15 中外制药株式会社 软胶囊剂
RU2186269C2 (ru) * 2000-02-25 2002-07-27 Дальневосточная государственная морская академия им. адмирала Г.И. Невельского Способ получения антифрикционного покрытия на тонкостенных стальных вкладышах опор скольжения
AU8252101A (en) * 2000-08-30 2002-03-13 Chugai Pharmaceutical Co Ltd Oct preparations
US7351869B2 (en) * 2002-11-18 2008-04-01 Teva Pharmaceutical Industries Ltd Crystallization method for purification of calcipotriene
GB0307865D0 (en) * 2003-04-04 2003-05-14 Novartis Ag Pharmaceutical composition
US7205006B2 (en) * 2003-09-25 2007-04-17 Prime Pharmaceutical Corporation Mahonia aquifolium extract, extraction process and pharmaceutical composition containing the same
FR2871696B1 (fr) * 2004-06-17 2006-11-10 Galderma Sa Composition topique pour le traitement du psoriasis
JP5161582B2 (ja) * 2004-11-22 2013-03-13 ウィスコンシン・アルムニ・リサーチ・ファウンデーション １７，２０（ｚ）−デヒドロビタミンｄ類似体およびそれらの使用
EP2526930B1 (de) 2005-06-01 2013-12-25 GlaxoSmithKline Intellectual Property Development Limited Vitaminformulierung
US20060286054A1 (en) * 2005-06-15 2006-12-21 Apollo Pharmaceutical, Inc. Pharmaceutical compositions for the treatment of psoriasis
ES2593047T3 (es) 2006-02-03 2016-12-05 Opko Renal, Llc Tratamiento de la insuficiencia y deficiencia de vitamina D con 25-hidroxivitamina D2 y 25-hidroxivitamina D3
ES2670029T3 (es) 2006-06-21 2018-05-29 Opko Ireland Global Holdings, Ltd. Terapia usando agente de repleción de la vitamina D y agente de reemplazo de la hormona de la vitamina D
US20080064669A1 (en) * 2006-08-29 2008-03-13 Rakefet Cohen Stable pharmacologically active compositions including vitamin D-containing and corticosteroid compounds with low pH compatibility
WO2008073174A2 (en) * 2006-09-08 2008-06-19 The Regents Of The University Of California Antimicrobial therapy
WO2008065514A2 (en) * 2006-11-29 2008-06-05 Glenmark Pharmaceuticals Limited Pharmaceutical compositions containing anhydrous calcipotriene
HUE073014T2 (hu) 2007-04-25 2025-12-28 Opko Renal Llc Eljárás a másodlagos hyperparathyreoidismus biztonságos és hatékony kezelésére és megelõzésére krónikus vesebetegség esetén
KR20190028822A (ko) * 2007-04-25 2019-03-19 사이토크로마 인코포레이티드 비타민 ｄ 화합물과 밀랍성 담체를 포함하는 경구 조절성 방출 조성물
US8592401B2 (en) 2007-04-25 2013-11-26 Proventiv Therapeutics, Llc Methods and compounds for vitamin D therapy
US11752158B2 (en) 2007-04-25 2023-09-12 Eirgen Pharma Ltd. Method of treating vitamin D insufficiency and deficiency
US7727562B2 (en) * 2007-06-21 2010-06-01 Blackman Steven T Liquid compositions containing solubilized benzoyl peroxide
EP2281058B1 (de) 2008-04-02 2016-06-29 Opko Ireland Global Holdings, Ltd. Verfahren, zusammensetzungen, verwendungen und kits mit eignung bei vitamin-d-mangel und verwandten störungen
WO2011123476A1 (en) 2010-03-29 2011-10-06 Cytochroma Inc. Methods and compositions for reducing parathyroid levels
JP5652723B2 (ja) * 2012-08-17 2015-01-14 フォーモサ・ラボラトリーズ・インコーポレーテッド マキサカルシトールの新しい結晶形態
JP2014144929A (ja) * 2013-01-29 2014-08-14 Daiichi Sankyo Healthcare Co Ltd ビタミン類を含有するニキビの予防又は治療用組成物
KR101847947B1 (ko) 2013-03-15 2018-05-28 옵코 아이피 홀딩스 Ⅱ 인코포레이티드 안정화되고 변형된 비타민 ｄ 방출 제형
US10220047B2 (en) 2014-08-07 2019-03-05 Opko Ireland Global Holdings, Ltd. Adjunctive therapy with 25-hydroxyvitamin D and articles therefor
JP7032322B2 (ja) 2016-03-28 2022-03-08 オプコ アイルランド グローバル ホールディングス リミテッド ビタミンｄ治療法

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4610978A (en) * 1983-03-22 1986-09-09 Yissum Research Development Company Of The Hebrew University Of Jerusalem Compositions containing 1α-hydroxycholecalciferol for topical treatment of skin disorders and methods employing same
GB2183156B (en) * 1985-03-14 1989-06-21 Chugai Pharmaceutical Co Ltd Composition for treating skin disease
US5145846A (en) * 1988-01-20 1992-09-08 Hoffmann-La Roche Inc. Vitamin D3 analogs
US5104864A (en) * 1988-08-02 1992-04-14 Bone Care International, Inc. Method for treating and preventing loss of bone mass
DK0398217T3 (da) * 1989-05-18 1994-02-14 Hoffmann La Roche Dehydrocholecalciferolderivater

Also Published As

Publication number Publication date
GB9004544D0 (en) 1990-04-25
ES2079063T3 (es) 1996-01-01
JPH05504959A (ja) 1993-07-29
DK0517797T3 (da) 1995-11-13
EP0517797A1 (de) 1992-12-16
US5292727A (en) 1994-03-08
DE69113029T2 (de) 1996-03-07
GR3017413T3 (en) 1995-12-31
EP0517797B1 (de) 1995-09-13
DE69113029D1 (de) 1995-10-19
WO1991012807A1 (en) 1991-09-05
AU7458891A (en) 1991-09-18

Similar Documents

Publication Publication Date Title
ATE127691T1 (de) Verwendung von vitamin-d-analoga zur behandlung von akne.
BR9814984A (pt) Processos para tratar condições fìsicas resultantes do declìnio pós-menopáusico de estrogênio em uma paciente pós-menopáusica e para reduzir o risco de fraturas ósseas osteoporóticas em uma paciente, e, conjunto para uso por uma comsumidora atormentada com, ou suscetìvel a, condições fìsicas resultantes do declìnio pós-menopáusico de estrogênio
ATE259215T1 (de) Zusammensetzung zur regulierung des hauterscheinungsbildes
DE10199020I1 (de) Galanthamin oder dessen Analoge zur Behandlung der Alzheimerschen Krankheit
NZ314839A (en) 1,25-Dihydroxy-16,23Z-diene-20-epi-16-ene-cholecalciferol (Vitamin D3) analogues
AU2003217055A1 (en) Protein for use in hypoxia related conditions
ES2126122T3 (es) Nitrato-aminoacido-disulfuros para la terapia de enfermedades del sistema cardio-circulatorio.
DE69428791D1 (de) Verwendung vonModafinil zur Behandlung von Atemstillstand im Schlaf und zentral erregten Atembeschwerden
MX9306960A (es) Composiciones de extracto de corteza de roble, compositiones sinteticasrelacionadas, y metodo para su utilizacion.
ATE112684T1 (de) Verwendung von igf-ii zur behandlung von knochenkrankheiten.
PT758241E (pt) Utilizacao de certos derivados de acido metanobisfosfonico para impedir o desprendimento de proteses e a migracao de proteses
ATE114473T1 (de) Ausrüstung für die verwendung bei der behandlung von osteoporose.
EP0401903A3 (de) Verwendung von Vanilloiden zur Behandlung von Erkrankungen der Atemwege
EP0307786A3 (de) Deutero-Cholecalciferolderivate, ihre Herstellung und pharmazeutische Anwendung
DE69635305D1 (de) Verwendung eines anti-interleukin-9 antikörpers zur herstellung eines medikamentes zur behandlung von asthma
FI962550A0 (fi) Deuterisoidut vaikuttavat aineet transdermaalisessa käyttötarkoituksessa
NZ326345A (en) Composition containing diosgenin
DE69326122D1 (de) Verwendung von wachstumsfaktor igf-ii zur beahandlung von gastrointestinalen störungen
ATE157010T1 (de) Amylin oder amylinanaloga enthaltende zusammensetzung, welche auch wahlweise insulin enthält, zur behandlung von anorexie und verwandten zuständen
ES2153689T3 (es) Pastilla de jabon antiseptico.
BR9708511A (pt) Utilização de compostos utilização de ácido 6-[3-(1-adamantil)-4-metoxifenil]-2naftóico e utilização do ácido 6-[3-(1-adamantil)-4-hidroxifenil]-2-naftóico
ES2061293T3 (es) Procedimiento para el acondicionamiento y/o purificacion de isocianatos organicos.
NO955347D0 (no) Hormonelt middel for terapi av akne samt anvendelse derav
ATE193206T1 (de) Zusammensetzung zur behandlung oder vorbeugung von herpes
DE69734349D1 (de) Behandlung von knochenleiden mit adrenomedullin